Soleus Capital Management, L.P. Trans Medics Group, Inc. Transaction History

Soleus Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $7.54 Million - $9.57 Million	-106,412 Reduced 86.44%	16,700 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $4.52 Million - $9.98 Million	123,112 New	123,112 $9.72 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $3.66 Million - $4.9 Million	55,200 Added 290.53%	74,200 $6.23 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $1.31 Million - $2.02 Million	-24,500 Reduced 56.32%	19,000 $1.44 Million
Q4 2022 Feb 14, 2023	SELL	$39.08 - $64.29 $5.15 Million - $8.47 Million	-131,800 Reduced 75.19%	43,500 $2.68 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $288,931 - $510,391	-9,155 Reduced 4.96%	175,300 $7.32 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $3.79 Million - $5.93 Million	184,455 New	184,455 $5.8 Million

391

31.3M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.15B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.